FDA describes informatics' role in regulatory makeover; risk-benefit analysis a topic at statistics workshop;

> "Enhancing Safety and Health Through Informatics" is a chapter in the newly published Advancing Regulatory Science for Public Health, which describes the FDA's Regulatory Science Initiative. Article | Document download

> Risk-benefit analysis joined missing data, meta-analysis and adaptive design at the recent FDA/Industry statistics workshop. Column

> The best way to plan a study is to work backwards, starting with the statement you want to truthfully make about the product; a statistician's input will ensure process integrity. Column

> Last year's H1N1 pandemic proved challenging for disease surveillance systems; mobile messaging may make the job easier. Article

> The recent Avandia decision shows that drug market approval is no longer a black-and-white activity; expect the FDA to become data-hungry in upcoming approvals. Article

> The Virginia Bioinformatics Institute to model immune responses to gut pathogens. Release

> Subject-recruitment specialist Acurian has named Kim Basciani director for eRecruitment. Release

> Electronic patient-reported outcomes solution provider PHT Corp has named Elizabeth Ricci its VP for product development. Article

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.